NSCLC (NON-SMALL CELL LUNG CARCINOMA)

Clinical trials for NSCLC (NON-SMALL CELL LUNG CARCINOMA) explained in plain language.

Never miss a new study

Get alerted when new NSCLC (NON-SMALL CELL LUNG CARCINOMA) trials appear

Sign up with your email to follow new studies for NSCLC (NON-SMALL CELL LUNG CARCINOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 1 Terminated 3

Russian lung cancer patients under the microscope: durvalumab in daily practice

Knowledge-focused Ongoing

This study tracks 250 adults with advanced non-small cell lung cancer in Russia who are receiving the drug durvalumab as part of their routine care. The goal is to see how safe and effective the treatment is outside of a controlled clinical trial, and to understand how long patie…

Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)

Sponsor: AstraZeneca • Aim: Knowledge-focused

Last updated May 22, 2026 13:51 UTC

NSCLC (NON-SMALL CELL LUNG CARCINOMA)

Get alerted when new NSCLC (NON-SMALL CELL LUNG CARCINOMA) trials appear

Russian lung cancer patients under the microscope: durvalumab in daily practice